Biofrontera Stock Investor Sentiment

BFRI Stock  USD 1.00  0.04  3.85%   
Under 56% of Biofrontera's investor base is looking to short. The analysis of the overall investor sentiment regarding Biofrontera suggests that many traders are alarmed. Biofrontera's investing sentiment shows overall attitude of investors towards Biofrontera.

Comfort Level 44

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Biofrontera's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Biofrontera.

Biofrontera Historical Sentiment

Although Biofrontera's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Biofrontera, such as negative comments on social media and news outlets, may cause fear in the market and push Biofrontera's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Biofrontera.

Biofrontera Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Biofrontera can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Biofrontera Historical Investor Sentiment

Investor biases related to Biofrontera's public news can be used to forecast risks associated with an investment in Biofrontera. The trend in average sentiment can be used to explain how an investor holding Biofrontera can time the market purely based on public headlines and social activities around Biofrontera. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Biofrontera's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Biofrontera and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Biofrontera news discussions. The higher the estimate score, the more favorable the investor's outlook on Biofrontera.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Biofrontera's Stock prices. Below is the latest headlines and news related to Biofrontera Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Biofrontera that are available to investors today. This information is accessible both publicly - through Biofrontera's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Biofrontera-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Biofrontera news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biofrontera relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biofrontera's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biofrontera alpha.

Biofrontera Largest EPS Surprises

Earnings surprises can significantly impact Biofrontera's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-03-08
2022-12-31-0.11-0.14-0.0327 
2022-04-08
2022-03-31-0.18-0.150.0316 
2021-12-31
2021-12-31-0.18-0.150.0316 
2023-05-12
2023-03-31-0.19-0.28-0.0947 
2025-03-13
2024-12-31-0.07-0.232-0.162231 
2022-11-14
2022-09-30-0.29-0.110.1862 
View All Earnings Estimates
over three months ago at thelincolnianonline.com         
Financial Review Biofrontera and Indaptus Therapeutics
news
over six months ago at www.macroaxis.com         
Acquisition by Borer John J Iii of 22000 shares of Biofrontera subject to Rule 16b-3
Macroaxis News
over six months ago at thelincolnianonline.com         
Biofrontera Inc. Short Interest Down 44.9 percent in December
news
over six months ago at finance.yahoo.com         
Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz-Photodynamic Ther...
Yahoo News
over six months ago at gurufocus.com         
Biofrontera Inc. Announces Achievement of Key Milestone In Phase
Gurufocus Stories at Macroaxis
over six months ago at thelincolnianonline.com         
Short Interest in Biofrontera Inc. Declines By 22.7
news
over six months ago at finance.yahoo.com         
Biofrontera Inc. Announces 100 RhodoLED XL Machines Now Placed in US Market
Yahoo News
over six months ago at thelincolnianonline.com         
Biofrontera Inc. Short Interest Up 116.9 percent in November
news
over six months ago at finance.yahoo.com         
Biofrontera Inc. to Present at The Benchmark Companys Upcoming Discovery One-on-One Investor Confere...
Yahoo News
over six months ago at www.macroaxis.com         
Acquisition by Hermann Luebbert of 190840 shares of Biofrontera subject to Rule 16b-3
Macroaxis News
over six months ago at thelincolnianonline.com         
Biofrontera Inc. Announces Private Placement of 4.2 Million Through 10.0 percent Senior Secured Conv...
news
over six months ago at finance.yahoo.com         
Biofrontera Inc. Closes a 4.2 Million Senior Secured Convertible Note
Yahoo News
over six months ago at globenewswire.com         
Biofrontera Inc. Closes a 4.2 Million Senior Secured Convertible Note
Macroaxis News: globenewswire.com
over six months ago at simplywall.st         
Biofrontera Third Quarter 2024 Earnings Misses Expectations
Simply Wall St News at Macroaxis
over six months ago at insidermonkey.com         
Biofrontera Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
There is far too much social signal, news, headlines, and media speculation about Biofrontera that are available to investors today. This information is accessible both publicly - through Biofrontera's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Biofrontera-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Biofrontera news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biofrontera relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biofrontera's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biofrontera alpha.

Biofrontera Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Biofrontera GAAP EPS of -0.47 misses by 0.26, revenue of 8.6M misses by 1.95M
05/16/2025
2
Acquisition by Hermann Luebbert of 113379 shares of Biofrontera at 4.77 subject to Rule 16b-3
05/29/2025
3
Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz Topical Gel, 10 percent Now Listed in FDA Orange Book
06/03/2025
4
Biofrontera Inc. Engages in Strategic Talks with Biofrontera AG BFRI Stock News
06/11/2025
5
PTA-Adhoc Biofrontera AG EXTENSION OF BIOFRONTERA INC. PAYMENT DEFERRAL - UPDATE - TradingView
06/26/2025
6
Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By ...
06/30/2025
7
Biofrontera Inc. Announces Plan to Offer 13.6 Million Shares BFRI Stock News
07/16/2025
8
Is Biofrontera Inc. a good long term investment - Free Stock Movement Tracking - Autocar Professional
07/23/2025
9
Moving Average Crossover Confirms Uptrend in Biofrontera Inc. - Fast Gaining Stock Screener Reports Released - metal.it
07/29/2025

Complementary Tools for Biofrontera Stock analysis

When running Biofrontera's price analysis, check to measure Biofrontera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera is operating at the current time. Most of Biofrontera's value examination focuses on studying past and present price action to predict the probability of Biofrontera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera's price. Additionally, you may evaluate how the addition of Biofrontera to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA